CORRECTING and REPLACING Veracyte Announces Presentation of New Clinical Utility Data at CHEST 2017 Showing Percepta Classifier Reduces Invasive Procedures in Lung Cancer Diagnosis
Go back to CORRECTING and REPLACING Veracyte Announces Presentation of New Clinical Utility Data at CHEST 2017 Showing Percepta Classifier Reduces Invasive Procedures in Lung Cancer Diagnosis| VERACYTE (NASDAQ: VCYT) | Delayed: 53.79 +0.60 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.19 | 52 Week High | $8.45 | |||
| Open | $52.79 | 52 Week Low | $4.21 | |||
| Day High | $54.12 | P/E | N/A | |||
| Day Low | $52.65 | EPS | $-1.52 | |||
| Volume | 844,898 | |||||
